FLASH: Jury deems J&J's DePuy ASR XL hip implant defective in design, orders $8.3M in damages

March 8, 2013 by Arezu Sarvestani

Johnson & Johnson defends its DePuy subsidiary's ASR XL hip devices after a California jury finds that the metal-on-metal implants were defectively designed, awarding plaintiff Loren Kransky $8.3 million in compensatory damages.

hip implant x-ray

A California jury ruled against Johnson & Johnson (NYSE:JNJ) and its DePuy subsidiary in finding that the company's ASR XL metal-on-metal hip implant was defectively designed.

The decision marks the highly anticipated close of the 1st of more than 10,750 such lawsuits against J&J. The jury dismissed claims that J&J failed to properly warn physicians about the risks of its metal hip implants, but ruled that the company was negligent and ordered J&J to pay $8.3 million in damages to patient Loren Kransky.

Sign up to get our free newsletters delivered right to your inbox.

J&J issued a statement today defending its hip implant design and noting that it plans to appeal the ruling, adding that the jury rejected the plaintiff's claim for punitive damages on top of compensatory damages.

"We believe ASR XL was properly designed, and that DePuy's actions concerning the product were appropriate and responsible," DePuy spokeswoman Lorie Gawreluk said in prepared remarks. "We plan to appeal the jury's decision on design defect pending the outcome of post-trial motions. We believe we have a number of valid grounds for appeal, notably that the court didn't let the company tell the jury about the Food & Drug Administration's review and clearance of the device."